Updated:
SpectraScience
SpectraScience is a San Diego-based medical device company that designs, develops, manufactures, and markets spectrophotometry systems. The WavSTAT Optical...
SpectraScience
SpectraScience is a San Diego-based medical device company that designs, develops, manufactures, and markets spectrophotometry systems. The WavSTAT Optical Biopsy System uses light to optically scan tissue, providing an immediate analysis. The system has FDA approval for sale in the U.S. and the CE Mark for the European Union.
General information
Firm type
other
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Frequently asked questions
What is SpectraScience?
SpectraScience is an entity headquartered in San Diego, California, with a website at spectrascience.com. No additional public information confirms its business model, investment activity, or ownership structure.
Is SpectraScience a family office?
There is no public evidence to confirm whether SpectraScience operates as a family office, a holding company, a private investment vehicle, or another entity type. The firm does not disclose its structure or purpose.
Who runs SpectraScience?
SpectraScience does not publicly name any principals, executives, or investment professionals. No leadership team is listed on its website or in public records.
What is SpectraScience's investment strategy?
No investment strategy, sector focus, or asset class preference has been disclosed by SpectraScience. There are no known portfolio companies or deals attributed to the firm.
Does SpectraScience manage capital?
SpectraScience has not publicly reported any AUM, capital deployment, or fund structures. Its financial status is entirely undisclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: